Spatial and temporal variability of the complex fractionated atrial electrogram activity and dominant frequency in human atrial fibrillation

Background: The presence of complex fractionated atrial electrograms (CFAEs) and high dominant frequencies (DFs) during atrial fibrillation (AF) have been demonstrated to be related to AF maintenance. Therefore, sequential mapping of CFAEs and DFs have been used for target sites of AF ablation. However, such mapping strategies are valid only if the CFAEs and DFs are spatiotemporally stable during the mapping procedure. We obtained spatially stable multi-electrode recordings to assess the spatiotemporal stability of CFAEs and DFs. Methods: We recorded electrical activity during AF for 10 min with a 64-electrode basket catheter (48 bipole electrode pairs) placed in the left atrium in 36 patients with AF (paroxysmal AF [PAF], n=16; persistent AF [PerAF], n=20). The spatial and temporal distribution of the CFAEs (fractionation interval 8 Hz) at 1-min intervals for 10 min were compared for each of the 48 bipoles. Results: The baseline CFAEs were located at 68.5±14.0% (32.9±6.7) of the 48 bipoles; however, the high DF sites were fewer (9.6±8.6% [4.6±4.1 bipoles]). The CFAEs sites did not change significantly during the 10-min recording period (kappa statistic: 0.71±0.24); however, the high DF sites changed significantly (kappa statistic: 0.07±0.19). These spatiotemporal changes in the CFAEs and high DFs did not differ between patients with PAF and PerAF. Conclusions: Regardless of the AF type, CFAEs sites, but not high DF sites, showed a high degree of spatial and temporal stability

Wavefront direction and cycle length affect left atrial electrogram amplitude

Background: The relationship between atrial electrogram (EGM) characteristics in atrial fibrillation (AF) and those in sinus rhythm (SR) are generally unknown. The activation rate and direction may affect EGM characteristics. We examined characteristics of left atrial (LA) EGMs obtained during pacing from different sites. Methods: The study included 10 patients undergoing pulmonary vein isolation for AF. Atrial EGMs were recorded from a 64-pole basket catheter placed in the LA, and bipolar EGM amplitudes from the distal electrode pair (1–2) and proximal electrode pair (6–7) from 8 splines were averaged. The high right atrium (HRA), proximal coronary sinus (CSp), and distal coronary sinus (CSd) were paced at 600 ms and 300 ms. Results: When the LA voltage at SR was ≥1.5 mV, bipolar voltages of the HRA were greater than those of the CSp, which were greater than those of the CSd, regardless of the pacing cycle length. The shorter pacing cycle length resulted in a reduction of the LA EGM voltage at sites of SR voltage ≥1.5 mV, but no significant difference was seen at sites where the SR EGM amplitude was between >0.5 and <1.5 mV. No significant differences were seen in intra-basket conduction times between pacing cycle lengths of 600 ms and 300 ms at any pacing site. Conclusion: The rate and direction-dependent reduction of the amplitude of atrial EGMs may explain, in part, the voltage discordance during SR and AF

A case of cardiac sarcoidosis presenting with double tachycardia

Although the most feared cardiac manifestation in cardiac sarcoidosis is the onset of ventricular arrhythmia, some patients may present with supraventricular arrhythmias. We present a rare case of cardiac sarcoidosis associated with double tachycardia manifesting as atrial flutter and ventricular tachycardia

Spatial and transmural repolarization, and dispersion of repolarization and late potentials evaluated using signal-averaged vector-projected 187-channel high-resolution electrocardiogram in Brugada syndrome

Background: Vector-projected 187-channel electrocardiograms (ECGs) were recorded in 45 patients with a Brugada-type ECG to evaluate spatial and transmural repolarization and dispersion of action potential duration in Brugada syndrome (BS). Methods: Corrected recovery time (RT-c, R wave peak to the first positive maximum derivative of the T wave with Bazett correction) and RT-c dispersion were calculated. The corrected T peak-end interval (T(p-e)-c, T wave peak to the end of the T wave with Bazett correction) and T(p-e)-c dispersion were calculated. Results: RT-c dispersion and T(p-e)-c interval were longer in patients with a type 1 ECG, but there was no significant difference in Tp-e dispersion between patients with a type 1 and those with a type 2/3 ECG. No significant correlation was noted between RT-c dispersion, T(p-e)-c dispersion, and symptoms. Late potentials (P=0.023) and a family history of sudden cardiac death (P=0.0017) were correlated with symptoms. Conclusions: Spatial dispersion of repolarization may constitute the electrocardiographic pattern of the Brugada type ECG and conduction disturbance in addition to repolarization abnormality may contribute to the development of malignant ventricular tachyarrhythmias

Brugada syndrome in the presence of coronary artery disease

Background: Brugada-type ECG changes have been described in association with various cardiac disease states including electrolyte abnormalities, myocardial pathologies, and mechanical cardiac abnormalities as well as drug therapies with particular medications. Such potential confounding factors make it difficult to diagnose Brugada syndrome on the basis of standard guidelines. Methods: To investigate the incidence of significant coronary artery disease in patients with Brugada-type ECG, coronary angiography was performed in 55 patients with Brugada-type ECGs. Results: Five of the 55 patients (9%) had significant coronary artery stenosis, and 3 out of these 5 were asymptomatic. Patients with coronary artery disease were older than in those without coronary artery disease (59.4±7.2 years vs. 49.0±13.8 years, P=0.03). An electrophysiological study was performed in 4 of the 5 patients, and ventricular fibrillation was induced in all 4. Conclusions: We conclude that patients with Brugada-type ECGs should be evaluated for coronary artery disease, and this is especially important for patients in whom age could be a risk factor for the disease

Left atrial remodeling: Regional differences between paroxysmal and persistent atrial fibrillation

Background: The mechanisms underlying self-perpetuation of persistent atrial fibrillation (AF) are not well understood. To gain insight into these mechanisms, we conducted a study comparing left atrial (LA) electroanatomic maps obtained during sinus rhythm between patients with paroxysmal AF (PAF) and patients with persistent AF (PerAF). Methods: The study included 23 men with PAF (age, 56.3±12.1 years) and 13 men with PerAF (age, 54.3±13.4 years). LA voltage mapping was performed during sinus rhythm. The clinical and electroanatomic characteristics of the two groups were evaluated and analyzed statistically. Results: The bipolar voltages at the LA septum, roof, and posterior wall, right superior pulmonary vein (PV) and its antrum, right superior PV carina, and right inferior PV antrum were significantly lower in patients with PerAF than in those with PAF. The bipolar voltages in other parts of the LA did not differ statistically between the two groups. Conclusion: PAF and PerAF seem to be characterized by differences in the regional voltage in the LA and PVs. The LA structural remodeling of PerAF may initiate from the right PVs and their antra and LA septum, roof, and posterior wall

Clinical implications of serum adiponectin on progression of atrial fibrillation

Background: The association between circulating adiponectin levels and atrial fibrillation (AF) is uncertain. We, therefore, investigated whether an increased serum adiponectin level is implicated in the long-term recurrence of AF after ablation therapy. Methods: Our study included 100 consecutive patients (88 men; median age, 57.9±10.9 years) who underwent catheter ablation for AF at our hospital between 2011 and 2013. The adiponectin and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were measured before ablation and compared between those in whom AF recurred and those in whom AF did not recur. Results: Elevation in adiponectin levels was significantly associated with female sex, non-paroxysmal AF, heart failure, higher NT-proBNP and matrix metallo-proteinase-2 levels, and lower body mass index. After a stepwise adjustment for any potential confounding variables, the adiponectin levels remained significantly associated with female sex (beta=0.2601, P=0.0041), non-paroxysmal AF (beta=0.2708, P=0.0080), and higher NT-proBNP levels (beta=0.2536, P= 0.0138). During the median follow-up period of 26.2 months, AF recurred in 48 of the 100 patients. Stepwise multivariate adjustment showed that an increased log-transformed NT-proBNP (Hazard ratio [HR], 2.18; 95% confidence interval [CI] 1.25â4.00; P=0.0055), longer duration of AF (HR, 1.87; 95%CI 1.01â3.76; P=0.0465), and decreased left ventricular ejection fraction (HR, 0.96; 95%CI 0.93â0.99; P=0.0391) were independent predictors of recurrent AF after catheter ablation, but adiponectin was not. Conclusions: Our data indicated that adiponectin was partially responsible for progression of AF, but the correlation between adiponectin levels and AF recurrence was not significant. Keywords: Atrial fibrillation, Adiponectin, NT-proBNP, Ablatio

Relationship between cardiopulmonary exercise testing parameters and heart failure risk (H2ARDD score) in atrial fibrillation

Background: A novel risk scoring system (H2ARDD) for estimating the incidence of heart failure (HF) events in atrial fibrillation (AF) has been developed, which represents points assigned for organic heart disease (2 points), anemia (1 point), renal dysfunction (1 point), diabetes (1 point), and diuretic use (1 point). We aimed to clarify whether H2ARDD score is related to cardiopulmonary exercise testing (CPX) parameters in patients with AF. Methods: The study population included 344 consecutive patients with AF who underwent CPX as initial screening between June 2004 and March 2012. The association between 4 CPX parameters and the incidence of HF events was analyzed by using multiple linear regression models. Results: The peak O2 uptake (peak V̇O2), anaerobic (gas exchange) threshold (AT), and ratio of the increase in V̇O2 to the increase in work rate (ΔV̇O2/ΔWR) were lower and the slope of the increase in ventilation to the increase in CO2 output (V̇E–V̇CO2 slope) was higher in patients with than in those without each H2ARDD score component. Accordingly, the parameters significantly increased or decreased according to H2ARDD score. With the multiple linear regression models, H2ARDD score was independently associated with each CPX parameter even after adjustment for various cofactors. Conclusions: H2ARDD score was independently associated with the well-established CPX parameters in patients with AF, suggesting a potential pathophysiological basis for a risk stratification system for predicting HF events in patients with AF